Evidence map›Paper›PMID 37891462›Full record

ArticleBMC infectious diseases2023

Inter-rater reliability of the infectious disease modeling reproducibility checklist (IDMRC) as applied to COVID-19 computational modeling research.

Darya Pokutnaya, Willem G Van Panhuis, Bruce Childers, Marquis S Hawkins, Alice E Arcury-Quandt, Meghan Matlack, Kharlya Carpio, Harry Hochheiser

Abstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Darya PokutnayaDepartment of Epidemiology, University of Pittsburgh, Pittsburgh, PA, United States of America. dap184@pitt.edu.
Willem G Van PanhuisOffice of Data Science and Emerging Technologies, National Institute of Allergy and Infectious Diseases, Rockville, MD, United States of America.
Bruce ChildersDepartment of Computer Science, University of Pittsburgh, Pittsburgh, PA, United States of America.
Marquis S HawkinsDepartment of Epidemiology, University of Pittsburgh, Pittsburgh, PA, United States of America.
Alice E Arcury-QuandtDepartment of Epidemiology, University of Pittsburgh, Pittsburgh, PA, United States of America.
Meghan MatlackDepartment of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA, USA.
Kharlya CarpioDepartment of Epidemiology, University of Pittsburgh, Pittsburgh, PA, United States of America.
Harry HochheiserDepartment of Biomedical Informatics, Intelligent Systems Program, and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, United States of America.

Funding

MIDAS Coordination CenterU24GM132013 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOCHHEISER, HARRY S · 2019 to 2023
$8.1M
NIGMS NIH HHS U24 GM132013NIGMS NIH HHS U24GM132013
6 · The paper itself

Abstract

backgroundInfectious disease computational modeling studies have been widely published during the coronavirus disease 2019 (COVID-19) pandemic, yet they have limited reproducibility. Developed through an iterative testing process with multiple reviewers, the Infectious Disease Modeling Reproducibility Checklist (IDMRC) enumerates the minimal elements necessary to support reproducible infectious disease computational modeling publications. The primary objective of this study was to assess the reliability of the IDMRC and to identify which reproducibility elements were unreported in a sample of COVID-19 computational modeling publications.

methodsFour reviewers used the IDMRC to assess 46 preprint and peer reviewed COVID-19 modeling studies published between March 13th, 2020, and July 30th, 2020. The inter-rater reliability was evaluated by mean percent agreement and Fleiss' kappa coefficients (κ). Papers were ranked based on the average number of reported reproducibility elements, and average proportion of papers that reported each checklist item were tabulated.

resultsQuestions related to the computational environment (mean κ = 0.90, range = 0.90-0.90), analytical software (mean κ = 0.74, range = 0.68-0.82), model description (mean κ = 0.71, range = 0.58-0.84), model implementation (mean κ = 0.68, range = 0.39-0.86), and experimental protocol (mean κ = 0.63, range = 0.58-0.69) had moderate or greater (κ > 0.41) inter-rater reliability. Questions related to data had the lowest values (mean κ = 0.37, range = 0.23-0.59). Reviewers ranked similar papers in the upper and lower quartiles based on the proportion of reproducibility elements each paper reported. While over 70% of the publications provided data used in their models, less than 30% provided the model implementation.

conclusionsThe IDMRC is the first comprehensive, quality-assessed tool for guiding researchers in reporting reproducible infectious disease computational modeling studies. The inter-rater reliability assessment found that most scores were characterized by moderate or greater agreement. These results suggest that the IDMRC might be used to provide reliable assessments of the potential for reproducibility of published infectious disease modeling publications. Results of this evaluation identified opportunities for improvement to the model implementation and data questions that can further improve the reliability of the checklist.

Indexed as

Communicable DiseasesCOVID-19ChecklistComputer SimulationHumansObserver VariationReproducibility of ResultsCoronavirus Disease 2019COVID-19EpidemiologyInfectious DiseaseModelingReproducibility

Identifiers

PMID37891462
PMCPMC10612332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.